Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Irbesartan 300mg tablets
0205052I0AAACAC
|
Irbesartan | Irbesartan | Cardiovascular System | 163,040 |
|
Irbesartan 150mg tablets
0205052I0AAABAB
|
Irbesartan | Irbesartan | Cardiovascular System | 140,770 |
|
Irbesartan 75mg tablets
0205052I0AAAAAA
|
Irbesartan | Irbesartan | Cardiovascular System | 87,188 |
|
Irbesartan 300mg/5ml oral suspension
0205052I0AAAGAG
|
Irbesartan | Irbesartan | Cardiovascular System | 19 |
|
Irbesartan 150mg/5ml oral suspension
0205052I0AAAFAF
|
Irbesartan | Irbesartan | Cardiovascular System | 12 |
|
Irbesartan 100mg/5ml oral suspension
0205052I0AAAMAM
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
|
Irbesartan 20mg oral powder sachets
0205052I0AAAJAJ
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
|
Irbesartan 300mg oral powder sachets
0205052I0AAAIAI
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
|
Irbesartan 30mg oral powder sachets
0205052I0AAAKAK
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
|
Irbesartan 37.5mg oral powder sachets
0205052I0AAALAL
|
Irbesartan | Irbesartan | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.